Complete Genomics Launches DNBSEQ-T7+ to Enhance High-Throughput Sequencing Capabilities
Complete Genomics Launches DNBSEQ-T7+ to Enhance High-Throughput Sequencing Capabilities
In a significant move for genomic research, Complete Genomics, a leading innovator in DNA sequencing technology based in the U.S., has announced the initiation of shipments for its DNBSEQ-T7+ high-throughput sequencing platform at the AGBT 2026 conference. This platform is poised to cater to the growing demands of large-scale genomic projects and production sequencing environments, addressing the needs of researchers and institutions striving for efficiency and cost-effectiveness.
Key Features of DNBSEQ-T7+
The DNBSEQ-T7+ system is designed with high-performance capabilities that optimize workflows for key applications in genomics, such as:
- - Large-scale whole genome sequencing (WGS)
- - Population genomics initiatives
- - Clinical research and translational genomics
- - High-volume production sequencing laboratories
One of the standout features of the DNBSEQ-T7+ is its streamlined workflow, which facilitates a rapid transition from library preparation to data analysis. This efficient system can deliver paired-end 150 base pair (PE150) reads within just 24 hours. It is capable of generating an impressive 48 billion reads from four independent flow cells in the same timeframe, making it ideal for high-throughput research contexts where both volume and speed are critical. In fact, the DNBSEQ-T7+ can process over 28,000 whole genomes per year, offering unprecedented scalability for large research groups.
Cost Efficiency and Data Quality
In addition to its high throughput, the DNBSEQ-T7+ maintains exceptional data quality. It achieves a per-base accuracy at Q40, providing a competitive price point of $1 per gigabase (Gb) or approximately $100 per genome. This pricing structure allows for cost-effective large-scale sequencing while giving researchers the flexibility to modulate the number of samples needed to reach their desired cost objectives. Moreover, its independent flow cell architecture supports a variety of run configurations, catering to both extensive batch processing and operational flexibility in high-demand scenarios.
With a US list price of $800,000, the DNBSEQ-T7+ is more affordable than many comparable high-throughput sequencers and boasts over seven times the daily output of similar mid-throughput options. Rob Tarbox, Vice President of Product and Marketing at Complete Genomics, emphasized that, "the launch of DNBSEQ-T7+ reflects our commitment to providing both scale and precision, essential for high-throughput sequencing customers. Researchers are increasingly focusing on balancing throughput, data quality, and operational efficiency, and T7+ is designed to meet these needs within a unified system."
Scientific Engagement at AGBT 2026
During the AGBT 2026 conference, Complete Genomics will engage participants through sponsored presentations and scientific discussions. These sessions will highlight the use of DNBSEQ platforms across various genomic studies, including:
- - Large-scale whole genome sequencing
- - Population genomics projects
- - Clinical and translational research applications
- - High-volume production sequencing operations
Attendees are encouraged to visit the Complete Genomics exhibit space at AGBT to learn more about the DNBSEQ-T7+, including its workflow integration, cost-effectiveness, and ongoing collaborative research initiatives. The full schedule of presentations and discussions can be found at Complete Genomics Events.
About Complete Genomics
Complete Genomics has positioned itself as a pioneering life sciences company dedicated to providing comprehensive DNA sequencing platforms, reagents, and software for diverse research applications. Since its inception in 2005, the organization has been at the forefront of cost-effective high-throughput sequencing innovations, contributing to over 10,900 published scientific papers globally. To learn more, visit Complete Genomics Website.
For Research Use Only. Not for use in diagnostic procedures.
Topics Consumer Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.